AMP Alternative Medical Products (AMP) and Little Green Pharma (LGP) have entered into the partnership for the distribution of full-plant cannabis extract oils in Germany.
The company, a wholly-owned subsidiary of Greenrise Global Brands, has been appointed as marketer and distributor of LGP medical cannabis extracts to pharmacies and clinics in Germany.
This will include LGP’s 20:5 LGP Classic and 10:10 LGP Classic extract oils in 30 and 50 milliliter sizes.
The news follows AMP’s announcement earlier this week that the company entered into a marketing and distribution agreement for the sale of Dronabinol in pharmacies with Eurox Pharma in the country.
Managing director of Little Green Pharma, Fleta Solomon, commented: “We set the strategic objective to be one of the leading medical cannabis extract producers and distributors in Europe, which means being a leader in Germany, the largest medical cannabis market in the world.
“Our partnership with Greenrise Global’s daughter company, AMP Alternative Medical Products GmbH, puts us on course to that path.”
Dr Stefan Feuerstein, president and director of Greenrise Global and managing director of AMP, commented: ”We are seeing the industry mature with the growth of pharmaceutical cannabis products over flowers and are excited about adding LGP medical cannabis extracts to our portfolio.”
LGP was among the first medical cannabis companies to produce and export medical cannabis oils to Germany.
The company is also the primary medical cannabis extract oil supplier in France’s two-year medical cannabis trials being conducted by the French National Agency for the Safety of Medicines and Health Products.
[activecampaign form=31]
